Myofi broma/myofi bromatosis is a rare mesenchymal disorder that is part of a heterogeneous group of approximately 20 disorders that are classifi ed primarily according to the proliferation of benign fi brous elements. Th ese lesions can arise during a wide range of ages, with many occurring in the fi rst decade of life, and they are slightly more common in males than females. Th e etiology of this disease is not well understood. Clinically, patients with myofi broma/myofi bromatosis present with various signs, ranging from superfi cial, cutaneous, purplish macules to freely movable subcutaneous masses to deep-seated fi xed lesions. Th e defi nitive diagnosis is made on histopathologic grounds. Th e destructive clinical behavior of myofi broma/ myofi bromatosis in the setting of insuffi cient pre-or perioperative diagnostic evaluations (e.g., a failure to perform fi ne-needle aspiration or frozen-section biopsy) may guide the clinician toward a radical surgical procedure rather than a simple excision.
Introduction
Myofi broma/myofi bromatosis refers to a rare group of unique spindle cell neoplasms. 1 In 1951, Williams and Schrum called this entity "congenital fi brosarcoma. " 2 Th ree years later, Stout described these tumors as "congenital multicentric and multinodular benign proliferations composed of spindle cells. " 3 In 1981, Chung and Enzinger used the term "infantile myofi bromatosis, " indicating both the myofi broblastic component and the predilection for infants. 4 In 1989, Smith et al 5 
and
Daimaru et al 6 referred to a solitary lesion as "myofibroma" and "myofi bromatosis, " respectively. Finally, in 2002, the World Health Organization decided on the terms "myofi broma" to describe the solitary form and "myofi bromatosis" to describe the multicentric form of benign neoplasms of contractile myoid cells arranged around thin vessels. 7 Th ese lesions can arise during a wide range of ages, with many occurring in the fi rst decade of life. Chung and Enzinger found that 88% of cases manifest before the age of 2 years, with 60% of those cases being present at birth. 4 According to some authors, they are the most common benign fi brous tumors of infancy. 8 Males appear to be aff ected more oft en than females. 4 Th e etiology is not well understood.
Clinically, myofi broma/myofi bromatosis presents with various features, ranging from superfi cial, cutaneous, purplish macules to freely movable subcutaneous masses to deep-seated fi xed lesions. Lesions typically range in size from 0.3 to 5.0 cm.
We report a case of solitary myofi broma in a 6-yearold boy. Th e lesion arose in the zygomatic area and aggressively caused bone destruction. We also discuss the current literature.
Case report
A 6-year-old boy was admitted to the Department of Otolaryngology at the University of İstanbul Cerrahpaşa Medical Faculty for evaluation of a tumor in the left cheek area that had enlarged progressively during the preceding 5 months. Prior to presentation, the patient had been treated elsewhere with long-term antibiotic therapy under the assumption that the mass represented an infectious process. However, when medical therapy did not relieve the swelling, the patient was referred to our clinic.
On examination, the patient had no pathology other than the buccal swelling. He appeared to be in good ntraoperative frozen-section examination revealed no defi nitive evidence of malignancy, but in view of the bone destruction noted on CT, a malignancy could not be ruled out. Th erefore, the zygomatic bone was excised almost completely, along with the tumor. Th e lateral orbital wall was cleaned by curettage. Surgical margins were free.
Macroscopically, the tumor had an elastic consistency. Histopathologic examination revealed a nodular arrangement of proliferated tumor cells (fi gure 2). A peripheral area of nodules contained plump myofibroblasts that formed fascicles and whorls. Th ere was no striking pleomorphism or anaplasia. Some of the nodules showed hyalinization that had a chondroid-like appearance. Th e center of the nodules was more cellular, consisting of rounded, plump, immature-appearing polygonal cells with somewhat hyperchromatic nuclei. Hemangiopericytoma-like branching vessels were observed in the tumoral proliferation. No calcifi cation or necrosis was noted. Mitotic activity was minimal. health, with no systemic symptoms, fever, weight loss, or night sweats. A conventional ENT examination and an endoscopic evaluation revealed the presence of a hard, painless, fi xed mass in the left zygomatic area. Th e mass measured approximately 3 × 3 cm. No additional pathology was found. A complete blood count and analysis of routine biochemical markers were obtained, and except for evidence of a mild iron defi ciency anemia, all values were within normal limits. Computed tomography (CT) of the maxillofacial area showed that the mass had caused destruction in the zygomatic bone and that it extended to the left lateral orbital wall (fi gure 1). Fine-needle aspiration biopsy was nondiagnostic.
A malignant process was suspected, and an excisional biopsy was undertaken via a left sublabial gingivobuccal incision. Th e periosteum of the canine fossa was elevated up to the lower margin of the orbit, and the posterolateral wall was reached laterally. When the hard infraorbital mass was located, it was found to have distinct borders. Th e mass was opened with a curette. Immunohistochemically, the tumoral myofi broblasts were positive with smooth-muscle actin and negative with S-100 protein and CD34. Th e fi nal pathology report identifi ed the tumor as a myofi broma with the possibility of multifocality at various sites and internal organs (i.e., congenital myofi bromatosis).
At 28 months of follow-up, the patient showed no evidence of recurrence.
Discussion
Myofi broma/myofi bromatosis is a rare mesenchymal disorder that is part of a heterogeneous group of approximately 20 disorders that are classifi ed primarily according to the proliferation of benign fi brous elements. 4 Myofi broma/myofi bromatosis occurs in three forms: as a solitary lesion, as multicentric lesions with visceral involvement, and as multicentric lesions without visceral involvement. 4 Visceral involvement (mainly gastrointestinal, pulmonary, and cardiac) is not usually found in the solitary form. 9 Approximately 74% of all cases are characterized by solitary lesions. 4 Children generally experience the multicentric forms, while adults usually have a solitary lesion. 10 While the etiology of this disorder is not well understood, several familial cases have been reported. Both autosomal-recessive and autosomal-dominant inheritance has been reported. Moreover, chromosomal abnormalities have been detected in some myofi bromas. 11, 12 Clinically, myofi bromas manifest as fi rm, painless, well-circumscribed nodules. Symptoms depend on the location of the tumor. 13 Th ey usually involve the soft tissues (primarily skin; less oft en muscle) and bone. Solitary forms frequently develop in the bones, particularly the craniofacial bones. 4, 14 Foss and Ellis reported 79 cases of oral and maxillofacial myofi broma/myofi bromatosis; all of the intraosseous (medullary) tumors in that series occurred in patients younger than 18 years. 15 Th e mandible was the most commonly involved location in that study. Reports of myofi bromas that develop directly in the medullary part of the zygomatic bone, especially in pediatric patients, are not common in the literature.
Imaging studies are helpful in the assessment, but they do not make a defi nitive diagnosis. Imaging is usually obtained to determine the extent of disease progression or regression and to look for recurrence. 13 CT typically shows a nonhomogeneous mass with distinct borders; with contrast enhancement, CT shows variability in the enhancement pattern. Intratumoral calcifi cations and possible zones of necrosis may also be noted. 16 On magnetic resonance imaging, myofi bromas usu-ally demonstrate a hypointense signal on T1 weighting and a hyperintense signal on T2 weighting. 17, 18 In cases of bone involvement, osteolytic lesions can be seen on x-rays and CT.
Th e defi nitive diagnosis is made on histopathologic examination, which shows spindle-shaped cells arranged in bundles or fasciculi appearing between fi broblasts and smooth-muscle cells. Th e nuclei of the cells are elongated, and the cytoplasm is eosinophilic. Th e surrounding matrix is rich in collagen. Mitoses are rare. Th e cells are round and less diff erentiated centrally, and there may be zones of necrosis, calcifi cation, or sheets of hyalinization.
In the histopathologic diff erential diagnosis, the presence of dense capillary channels may lead to a misdiagnosis of hemangiopericytoma; a myofi broma is diff erentiated from a hemangiopericytoma by the presence of a peripheral cellular component in the former. Moreover, a myofi broma is diff erentiated from a desmoid tumor by its less-aggressive nature, by the presence of hyalinization, and by its central hemangiopericytomalike appearance. Finally, a myofi broma is diff erentiated from a fi brosarcoma by its lack of marked atypia, mitoses, and cellularity. Diff erentiation from leiomyoma, leiomyosarcoma, fi brous histiocytoma, and nodular fasciitis also should be made.
Th e diagnosis is confi rmed by immunohistochemistry. Th e smooth-muscle markers actin and vimentin are positive, and markers for CD1a, cytokeratin, S-100 protein, and desmin are negative. 9 Patients with the solitary unifocal form of this disease have an excellent prognosis, whereas those with the mul- ifocal form may face a fatal outcome. Visceral lesions are associated with greater tumor-related morbidity and mortality. 19 However, Chung and Enzinger reported that 30% of children with infantile multifocal myofi bromatosis experienced a spontaneous regression. 4 Regression is oft en manifested histologically in the form of central necrosis of the tumor, and the underlying mechanism would appear to involve a massive apoptosis. 20 However, the literature contains no other large series that found so much spontaneous regression.
Th e choice of treatment varies according to the type of disease. Th e preferred treatment is complete resection, especially for solitary unifocal tumors. If this is not possible, conservative debulking can be performed. 21, 22 Reported recurrence rates aft er surgery range from 10 to 31% within 10 to 15 years aft er the initial presentation. 4 In our case, we performed a left sublabial gingivobuccal incision with wide periosteal elevation through the lower margin of the orbit, similar to a hemifacial degloving technique. Although this approach could not provide a wide view over the zygomatico-orbital area, as does an open approach, our choice was guided by the patient's young age and the inability of the histopathologic analysis to rule out a malignancy. Our procedure was limited by an especially narrow operative fi eld and by the presence of the infraorbital nerve and the zygomatic branches of the facial nerve. We did perform facial nerve monitoring during the resection.
In view of the fact that the prognosis is poor for patients with a large number of lesions and/or visceral involvement, the preferred management option is observation and close follow-up. Radiotherapy has no role in treatment, and chemotherapy is used only when there is extensive disease involving internal organs or neural structures. 23, 24 Because the possibility exists for spontaneous regression, some authors have proposed a policy of therapeutic abstention in disease sites where surgery might have a detrimental impact on the patient's physical appearance or function. 19, 25, 26 Th e destructive clinical behavior of myofi broma/ myofi bromatosis in the setting of insuffi cient pre-or perioperative diagnostic evaluations (e.g., a failure to perform fi ne-needle aspiration or frozen-section biopsy) may guide the clinician toward a radical surgical procedure rather than a simple excision.
